Statistics

Total Visits

Views
Brigatinib Versus Crizotinib in Advanced ALK Inhibitor-Naive ALK-Positive Non-Small Cell Lung Cancer: Second Interim Analysis of the Phase III ALTA-1L Trial53

File Visits

Downloads
36218-371.pdf27

Select a period of time:

Number of views in the range

Views
Brigatinib Versus Crizotinib in Advanced ALK Inhibitor-Naive ALK-Positive Non-Small Cell Lung Cancer: Second Interim Analysis of the Phase III ALTA-1L Trial32

Number of downloads in the range

Downloads
36218-371.pdf5

Views

Views
January 20250
February 20253
March 202518
April 202510
May 20250
June 20250
July 20251
Download CSV file
 untranslated
 untranslated

Number of downloads in the period of time

  • Downloads
  • January 2025
    0
  • February 2025
    0
  • March 2025
    0
  • April 2025
    2
  • May 2025
    3
  • June 2025
    0
  • July 2025
    0
  • Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore18
Hong Kong10
United States4
 

Top countries by downloads

Downloads
Hong Kong2
 

Top cities views

Views
Hong Kong10
Yuma1
 

Top cities by downloads

Downloads
Hong Kong2